Table 3.

Annual age-adjusteda mortality rates per 100,000 for selected cancers by race/ethnicity (New York, 2008–2014; female)

Selected black subgroupsSelected Hispanic subgroups
Non-Hispanic whiteAsian/Pacific IslanderNon-Hispanic black allgU.S.-born blackCaribbean-born blackHispanic allgPuerto RicanDominicanCentral AmericanSouth American
n = 91,196n = 3,807n = 17,649n = 12,9243,475n = 9,628n = 4,597n = 1,941n = 882n = 1,424
Rate (95% CI)Rate (95%CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)Rate (95% CI)
Oral cavity and pharynx1.1 (1.0–1.2)1.2 (0.9–1.5)1.5 (1.3–1.7)1.9 (1.6–2.3)0.8 (0.5–1.5)0.9 (0.7–1.1)1.1 (0.8–1.5)0.8 (0.5–1.3)0.7 (0.3–1.6)0.7 (0.4–1.2)
Esophagus1.7 (1.6–1.8)0.6 (0.4–0.9)1.9 (1.6–2.2)2.6 (2.2–3.0)0.8 (0.5–1.5)1.1 (0.9–1.3)1.6 (1.2–2.0)0.8 (0.5–1.3)1.0 (0.4–1.9)0.8 (0.4–1.3)
Stomach2.1 (2.0–2.2)4.0 (3.5–4.7)4.6 (4.2–5.0)4.5 (4.0–5.0)4.5 (3.8–5.5)3.9 (3.5–4.3)3.8 (3.2–4.4)2.8 (2.2–3.6)6.7 (5.0–8.6)4.5 (3.6–5.6)
Colorectum12.3 (12.0–12.6)8.0 (7.2–8.8)15.2 (14.4–15.9)17.3 (16.3–18.2)11.1 (10.0–12.5)10.0 (9.3–10.6)13.3 (12.1–14.5)8.4 (7.2–9.7)9.4 (7.4–11.8)6.5 (5.4–7.8)
Liverb2.9 (2.8–3.1)4.9 (4.3–5.6)4.0 (3.6–4.4)4.5 (4.0–5.0)3.0 (2.4–3.9)5.2 (4.7–5.7)6.2 (5.5–7.1)5.5 (4.5–6.6)4.7 (3.3–6.4)4.4 (3.4–5.4)
 1945–1965 birth cohortc0.7 (0.7–0.8)1.0 (0.8–1.4)1.6 (1.4–1.9)2.2 (1.8–2.7)0.6 (0.3–1.4)1.6 (1.3–1.8)2.2 (1.8–2.8)1.2 (0.8–1.9)1.1 (0.5–2.3)1.1 (0.7–1.8)
 Outside birth cohort2.2 (2.1–2.3)3.9 (3.3–4.7)2.4 (2.1–2.7)2.3 (1.9–2.8)2.3 (1.8–3.4)3.6 (3.2–4.2)4.0 (3.3–5.0)4.2 (3.3–5.6)3.7 (2.4–7.9)3.3 (2.3–4.6)
Pancreas10.2 (9.9–10.4)6.5 (5.7–7.2)11.3 (10.6–11.9)13.2 (12.4–14.1)7.0 (6.1–8.1)7.1 (6.5–7.6)8.4 (7.5–9.3)5.4 (4.5–6.5)7.3 (5.6–9.4)6.7 (5.5–8.0)
Lungd39.4 (38.9–39.9)15.6 (14.5–16.8)29.3 (28.3–30.3)41.6 (40.1–43.1)8.3 (7.4–9.5)14.4 (13.7–15.2)20.6 (19.2–22.1)11.0 (9.6–12.5)9.3 (7.3–11.6)9.4 (8.0–11.0)
Female breast21.0 (20.7–21.4)9.1 (8.3–9.9)27.9 (27.0–28.9)31.2 (30.0–32.6)20.7 (19.2–22.5)14.7 (13.9–15.4)18.1 (16.8–19.5)13.3 (11.9–14.9)15.1 (12.6–17.8)11.2 (9.7–12.8)
 Premenopausale3.0 (2.8–3.1)1.8 (1.5–2.2)5.7 (5.2–6.2)6.0 (5.4–6.7)5.0 (4.2–6.1)2.4 (2.1–2.7)2.9 (2.4–3.5)2.8 (2.2–3.5)1.6 (1.0–2.5)2.2 (1.6–2.9)
 Postmenopausal18.0 (17.8–18.4)7.2 (6.5–8.0)22.3 (21.4–23.1)25.2 (24.1–26.4)15.7 (14.5–17.2)12.3 (11.6–13.0)15.2 (14.0–16.5)10.6 (9.3–12.0)13.5 (11.1–16.1)9.0 (7.7–10.5)
Cervix1.8 (1.7–1.9)1.6 (1.2–1.9)4.4 (4.0–4.8)4.8 (4.3–5.4)3.7 (3.1–4.6)2.9 (2.6–3.2)3.9 (3.3–4.5)2.8 (2.2–3.6)2.5 (1.7–3.7)2.2 (1.6–2.9)
Endometrium4.9 (4.7–5.1)2.1 (1.7–2.5)10.2 (9.7–10.8)10.8 (10.0–11.5)8.5 (7.6–9.7)4.1 (3.8–4.6)4.8 (4.1–5.5)3.8 (3.0–4.7)7.6 (5.8–9.7)2.5 (1.8–3.3)
Ovary8.4 (8.2–8.6)4.5 (3.9–5.1)6.6 (6.1–7.1)7.0 (6.4–7.6)5.2 (4.5–6.2)4.8 (4.4–5.3)5.6 (4.8–6.4)4.1 (3.3–5.0)6.4 (4.9–8.3)4.0 (3.1–5.0)
Kidney2.2 (2.1–2.3)1.0 (0.8–1.4)1.7 (1.4–1.9)2.1 (1.8–2.5)0.7 (0.4–1.4)1.1 (0.9–1.3)1.4 (1.0–1.8)0.6 (0.3–1.0)1.4 (0.7–2.4)1.0 (0.6–1.6)
Bladder2.6 (2.5–2.7)1.2 (0.9–1.5)2.2 (1.9–2.5)2.6 (2.3–3.0)1.4 (1.0–2.2)1.5 (1.3–1.8)2.1 (1.7–2.6)0.9 (0.6–1.4)1.5 (0.7–2.6)0.8 (0.4–1.4)
Brain3.7 (3.5–3.8)1.5 (1.2–1.9)1.8 (1.5–2.0)1.7 (1.4–2.0)1.9 (1.4–2.7)2.0 (1.8–2.3)2.4 (1.9–2.9)2.1 (1.6–2.8)1.3 (0.7–2.1)1.9 (1.3–2.6)
CUP7.4 (7.2–7.6)3.2 (2.7–3.8)7.3 (6.8–7.8)8.7 (8.0–9.4)4.9 (4.2–5.9)4.6 (4.2–5.1)5.2 (4.5–5.9)4.4 (3.6–5.4)5.1 (3.7–6.8)4.1 (3.2–5.2)
NHL4.8 (4.6–5.0)2.5 (2.1–3.0)3.5 (3.1–3.8)3.5 (3.1–4.0)3.0 (2.5–3.9)3.5 (3.1–3.9)4.1 (3.5–4.8)3.2 (2.5–4.0)3.3 (2.2–4.7)3.4 (2.6–4.4)
Myeloma2.3 (2.2–2.5)0.9 (0.6–1.2)4.3 (4.0–4.7)4.6 (4.1–5.2)3.9 (3.2–4.8)2.2 (1.9–2.6)2.4 (1.9–3.0)3.3 (2.6–4.2)1.8 (1.0–2.9)1.5 (1.0–2.2)
Leukemia5.1 (5.0–5.3)2.5 (2.0–2.9)3.6 (3.3–4.0)3.8 (3.3–4.2)2.7 (2.2–3.6)3.9 (3.5–4.3)4.3 (3.7–5.0)3.6 (2.9–4.5)3.9 (2.7–5.3)3.2 (2.4–4.1)
All-sites-combinedf145.4 (144.4–146.3)76.5 (74.0–79.1)151.7 (149.5–154.0)178.2 (175.1–181.3)99.9 (96.5–103.5)96.2 (94.3–98.2)119.7 (116.2–123.2)83.5 (79.7–87.4)98.3 (91.7–105.2)75.8 (71.8–80.0)
  • Abbreviations: CUP, cancers of unknown primary; NHL, non-Hodgkin lymphoma.

  • a2000 U.S. Standard Population.

  • bIncludes intrahepatic bile duct.

  • cHigh HCV prevalence birth cohort; age-adjusted rates for liver cohorts originate from different age groups and thus should only be compared across populations, not within.

  • dIncludes bronchus.

  • eCutoff of age 50 used to approximate pre- and postmenopausal status; age-adjusted breast cohorts originate from different age groups and thus should only be compared across populations, not within.

  • fAll-sites-combined includes those listed as well as those not listed here.

  • g"All" includes those who fall in this race/ethnicity category but not specifically studied here.